The significance of neuropeptide Y (NPY) in the cerebral circulation has been examined in the rat us ing immunocytochemistry, isolated cerebral artery prep arations, and quantitative autoradiographic techniques for determining local CBF and glucose utilisation. In the rat the middle cerebral artery and the lenticulostriate ar tery from which blood is supplied to the caudate nucleus were found to be invested with numerous perivascular NPY immunoreactive nerve fibres. NPY (3-300 nM) con tracted rat middle cerebral artery segments in a concen tration-dependent manner. Intracerebral microinjections of NPY (200 pmol) or vehicle (1 J.11) were performed in rats after full recovery from anaesthesia via previously implanted guide cannulae. Following injection of NPY into the striatum, local blood flow was markedly de creased by 36% throughout the ipsilateral caudate nu cleus (e.g., from 104 ± 25 to 67 ± 15 mllOO g-I min -I;
Although an increasing number of putative neu rotransmitters are being discovered in the brain and in perivascular nerve fibres on cerebral vessels (Ed vinsson, 1985; Uddman and Edvinsson, 1989) , the functional role of these substances is not known. Of the perivascular peptides present in the cerebrovas culature, the 36-amino acid peptide neuropeptide Y (NPY; Tatemoto, 1982) is a most promising candi date to be involved in the regulation of the cerebral circulation. Dense plexuses of NPY immunoreac tive nerve fibres have been demonstrated around cerebral arteries of cat, guinea pig, and humans in ter alia (Edvinsson et ai., 1983 (Edvinsson et ai., , 1984 (Edvinsson et ai., , 1987a Allen et ai., 1984; Uddman et ai. , 1985) . NPY has also mean ± SD), whereas glucose use in this region was not altered significantly (e,g., 73 ± 8 and 74 ± 10 J.1mol 100 g-I min-I with vehicle and NPY, respectively). Intra striatal NPY did not alter CBF or glucose use in the ma jority of other brain areas, including all of the 40 contra lateral regions examined and almost all regions within the ipsilateral hemisphere. In a small number of highly dis crete brain areas remote from the injection site (e.g., amygdala), there were significant reductions in blood flow with minimal changes in glucose use. Since NPY is present around rat cerebral blood vessels, is capable of evoking their contraction, and has the ability to produce reductions in blood flow independently of oxidative me tabolism, this neuropeptide may be of major importance in cerebrovascular regulation. Key Words: Amygdala Autoradiography-[14C]2-Deoxyglucose-Entorhinal cortex-[ 14C] Iodoantipyrine. been shown to have extremely potent vasoconstric tor effects on cerebral arteries in vitro and feline cerebral arterioles in situ (Edvinsson et ai., 1983 (Edvinsson et ai., , 1984 (Edvinsson et ai., , 1987a . Injections of NPY into the internal carotid artery of the rat putatively elicit profound sustained reductions in CBP (Allen et ai., 1984) , although the evidence is far from conclusive (Tuor et ai., 1985) . Any study in which the influence of an intravascular vasoactive neurotransmitter-neuro modulator on local CBP is examined must ensure that it gains access to the vascular smooth muscle across the blood-brain barrier and that changes in flow are not secondary to alterations in cerebral metabolic demand (MacKenzie et ai., 1976; Bernt man et ai., 1978; McCulloch and Edvinsson, 1980; McCulloch et ai., 1982) .
Owing to interspecies and interregional variations in innervation and vasoactive responsiveness asso ciated with putative vasoactive neurotransmitters Hamel et ai. , 1985) , the present study fo cussed on a single spe cies (the rat) and a single region of the CNS (the caudate nucleus) to elucidate the influence of the vasoconstrictor peptide NPY upon cerebral tissue perfusion. Initially we established that there are NPY-immunoreactive nerve fibres on those rat ce rebral arteries that supply blood to the caudate nu cleus (e.g., middle cerebral artery and lenticulostri ate artery) and that the rat middle cerebral artery contracts in response to the application of NPY. In addition, in the conscious rat, intrastriatal adminis tration of NPY selectively decreased local CBP in dependently of changes in local glucose utilisation within the caudate nucleus. Thus, of the perivascu lar peptides present in the cerebral circulation, NPY has the capability of exerting a physiological or pathological influence on the cerebral circula tion, e.g. , in conditions with cerebrovascular con strictions such as migraine with aura or in subarach noid haemorrhage.
METHODS

Immunocytochemistry
The innervation of cerebral arteries by NPY -like im munoreactive fibres was examined in Sprague-Dawley rats (200-250 g) . Arterial specimens from the middle ce rebral and the lenticulostriate arteries were dissected free and processed as described previously (U ddman et al., 1985) . Briefly, the specimens were removed and fixed in a solution of picric acid (15%) and formaldehyde (2%) overnight and thoroughly rinsed in a phosphate buffer containing 20% sucrose at 4°C for 48 h. The vessels were then either stretched on chrome-alum-subbed microscope slides as whole mounts or frozen on dry ice and sectioned at 15-lJ.m thickness in a cryostat. The preparations were processed for the demonstration of NPY -like immunore activity using an indirect immunofluorescence method (Coons et al., 1955) with NPY antiserum. The NPY an tiserum (NPYY/2; gift of Dr. P. C. Emson, Cambridge, U.K.) was raised in a rabbit against natural porcine NPY and used in dilution (1:500). Its specificity has been examined previously both with a radioimmunoassay and at the immunocytochemical level (Sundler et al., 1983; Uddman et al., 1985) . The site of the antigen-antibody reaction was revealed by fluores cein isothiocyanate-Iabelled goat anti-rabbit IgG (Dako, Copenhagen, Denmark) diluted 1 :20 and applied for 1 hat room temperature. Sections incubated with NPY antise rum and inactivated by the addition of excess antigen (10 IJ.g ml-1 NPY per diluted antiserum) served as controls. For further details see Uddman et al. (1985) .
Vasomotor responses of rat cerebral arteries in vitro
The effects of NPY on rat middle cerebral artery in vitro were investigated in vessel preparations from 10 Sprague-Dawley rats (200-250 g) using a preparation de scribed in detail previously (Hogestatt et al., 1983) . Briefly, the rats were decapitated and circular segments of the middle cerebral artery were removed, placed in a bicarbonate buffer solution, and divided into segments of J Cereb Blood Flow Metab, Vol. 10, No.5, 1990 1-2 mm in length. The vessel specimens (with intact en dothelium) were then mounted in small tissue baths. Two stainless-steel wires were gently inserted into the vessel lumen with the aid of a low-power microscope. One spec imen holder was connected to a Grass FT03C force displacement transducer for recording of isometric ten sion, while the other was attached to a movable unit per mitting precise adjustment of resting tension. Following an equilibration period of 1.5 h, the resting tension was adjusted to 2 mN. The vessel segments were initially ex posed to a 124 mM potassium-rich solution for a brief period, which produced a strong contraction, to check preparation viability. The bath and buffer solutions were kept at 37°C and bubbled continuously with 5% CO 2 and 95% O 2 , resulting in a pH of -7.4. NPY (Peninsula) was dissolved and diluted in 0.9% NaCI and added directly to the tissue baths in volumes of 25 1J.l. The concentrations reported are the final molar concentration in the tissue bath.
Autoradiographic determination of local CBP and glucose use
The evaluation of the effect of NPY on the relationship between local blood flow and glucose use was performed in 24 male Sprague-Dawley rats (300-350 g). The rats were anaesthetised with halothane (-2%) and mounted in a stereotaxic frame. The skull was exposed with a midline scalp incision and a small burr hole was drilled through the bone (coordinates of 2.6 mm lateral and 1.5 mm an terior to bregma). A stainless-steel guide cannula of ex ternal diameter 0.66 mm was positioned through the cor tex and corpus callosum into the striatum to a depth of 5.5 mm from the cranium. The guide cannula was secured in place with dental acrylic cement and the animal was re turned to its cage and allowed to recover for 7-14 days.
On the day of the experiment the animal was anaesthe tised with 1 % halothane for -45 min. Catheters were in serted into the femoral vessels and the incision sites were closed and infiltrated with a local anaesthetic gel (2% xy locaine). The lower trunk of the rat was immobilised with a loose-fitting plaster cast that was taped to a lead brick. The halothane was discontinued and the animal allowed to recover fully from anaesthesia for at least 2 h.
The injection needle (external diameter, 0.33 mm), which was connected by polyethylene tubing to a mi crosyringe, was inserted into the guide cannula to a depth of 6.5 mm (1 mm beyond its tip). Following the insertion of the needle, the rat was left undisturbed for 5 min. One microliter of either vehicle or NPY (200 pmo!) dissolved in deionised water (1 IJ.I) was injected slowly by hand at a constant rate. All solutions contained an inert dye (0.1 % Evans blue) to allow visualisation of the injection site. The measurements of local CBF were performed at 20 min after completion of the injection. Measurements of local glucose use were initiated 10 min after the injection was completed and the injection needle remained in place for the 45-min duration of the experiment. In addition to the systematic evaluation of the relationship between CBP and glucose use after intrastriatal NPY, the tempo ral nature of the cerebral circulatory responses and their dose dependency were examined briefly. The effects on CBP of intrastriatal NPY (200 pmo!) at 10 and at 55 rriin after the injection were determined with the same exper imental procedures. The effects of intrastriatal NPY at lower concentrations (2 and 20 pmo!) on CBP 20 min after the injection were also examined. The absence of infor mation on the effects of these procedures on glucose use and the small group sizes (n = 3) preclude detailed sta tistical evaluation.
Local CBF was measured using the [14Cliodoantipyrine quantitative autoradiographic method (Sakurada et aI., 1978) . For technical details relevant to our laboratory see McCulloch et ai. (1982) . Briefly, the tracer ([14Cliodo antipyrine, 50 J.LCi in 0.7 ml of isotonic saline) was infused at a constantly increasing rate over 60 s, during which period 15-18 timed arterial blood samples were collected from a freely flowing catheter onto preweighed filter pa per discs. At 1 min, the animal was decapitated and the brain was removed and prepared for autoradiography per formed as described below. The filter paper discs were reweighed and processed and the tracer concentrations in the blood samples were determined by liquid scintillation counting.
The rate of regional glucose utilisation was measured with a quantitative autoradiographic method using [14C]2_ deoxyglucose as the tracer (Sokoloff et aI., 1977) . Briefly, the measurement of local cerebral glucose use was initi ated by the intravenous injection of a 30-s pulse of [14C]2_ deoxyglucose (50 J.LCi in 0.7 ml saline). Over the subse quent 45 min a total of 14 samples of arterial plasma (40 J.Ll) were obtained and the concentration of glucose in plasma was determined by enzymatic assay. The plasma concentration of radioactive tracer was obtained by liquid scintillation analysis. At the end of the 45-min period the rats were decapitated and the brains were removed and prepared for autoradiography.
In the investigation of both CBF and glucose use, the brain was frozen in isopentane ( -42°C) and >250 semi serial cryostat sections were mounted and exposed to x ray film for 7-10 days. Using a computerised densitome ter with a predetermined frame size for each region (0.02-0.25 mm 2 ), the mean optical density was determined for each structure. The same neuroanatomical criteria and size of measurement frame were employed in the densi tometric analysis of both the CBF and the glucose use autoradiograms. All densitometry was performed by the same individual. Local tissue concentrations of tracer were calculated using previously calibrated standards that were exposed simultaneously with the sections. Lo cal CBF was calculated for 40 regions of the CNS by means of the equation developed by Sakurada et al. (1978) using (a) the tracer concentration in the tissue, (b) the arterial concentration of tracer over the period of in fusion, and (c) a partition coefficient of 0.8 for the rat. The local rate of glucose utilisation in the same 40 regions of the CNS was calculated by means of the operational equation of Sokoloff et al. (1977) using (a) the concentra tion of tracer within each brain region, (b) the arterial concentration of tracer over 45 min, and (c) the appropri ate lumped constant and rate constants for the rat.
Data are presented in the text and tables as means ± SD and as means ± SEM in the figures. For each region formal statistical comparisons were made only between CBF (or glucose use) of vehicle-and NPY (200 pmol)treated rats for the same hemisphere (i.e., ipsilateral ve hicle and ipsilateral NPY; contralateral vehicle and con tralateral NPY) by the two-tailed Student t test to obviate the need for correction for multiple comparisons. The accepted level of probability (p) was set at <0.02 because of the number of brain areas being studied. Comparisons that yielded p values between 0.02 and 0.05 are noted in passing in the text.
The relationship between local CBF and glucose use was assessed using a repeated measures analysis of vari ance on log-transformed data. The comparisons being made within the repeated measures analysis of variance were controlled for by means of the conservative test of Greenhouse and Geisser (see McCulloch et al., 1982) . The results of linear regression analysis are included only for comparison with the work of others, though the weak nesses of this statistical approach have been discussed at length previously (McCulloch et aI., 1982) .
RESULTS
Immunocytochemistry
Well-developed nerve plexuses of NPY-like im munoreactive nerve fibres were found in the adven titia or at the adventitia-media border of the middle cerebral and the lenticulostriate arteries. NPY-like immunoreactive fluorescence was also observed within fibres located on small arteries that pene trated the brain parenchyma (lenticulostriate arter ies) from which the blood supply to the caudate nucleus is derived ( Fig. O .
Cerebral arteries in vitro
NPY elicited a concentration-dependent contrac tion of ring segments of the rat middle cerebral ar tery. The threshold concentration for contraction to NPY was �2 nM and the concentration of peptide that elicited half-maximal contraction of the middle cerebral artery was 21 ± 8 nM. The maximum con traction of the rat middle cerebral artery in response to NPY (0.5-1 /-LM) was 0. 20 ± 0.08 mN.
Striatal blood flow and glucose-use
The local administration of NPY into the dorso medial caudate nucleus did not result in any signif icant change in monitored physiological variables such as mean arterial blood pressure, arterial pH, arterial glucose concentration, or arterial oxygen and carbon dioxide tensions (Table O. The intrastriatal injection of NPY (200 pmol) re duced significantly the level of blood flow in the body of the caudate nucleus into which it was ad ministered ( Table 2) . The reductions in blood flow extended into the tail of the caudate nucleus ( Table  2) . The intrastriatal injection of NPY (200 pmol) did not alter significantly global glucose utilisation in the caudate nucleus (Table 3) , although there were small regions of diffuse reductions in glucose use interspersed with punctate areas in which glucose use was modestly elevated relative to adjacent ar eas. There were no changes in either local blood flow or glucose use in the contralateral striatum fol lowing unilateral administration of NPY. In conse quence, the marked effects of NPY on striatal blood flow and its minimal effects on striatal glucose util isation could be readily distinguished on visual in spection of the autoradiograms (Pig. 2).
The dose dependency of the cerebrovascular re sponse in the striatum to NPY was examined in a more limited number of animals. Reductions in eBP were observed after intrastriatal administra tion of NPY (2 and 20 pmol) that were of similar magnitude to those observed with the highest con centration (Pig. 3). The additional measurements of eBP at 10 and 55 min revealed that the maximum response to NPY had occurred at 20 and 55 min but not at 10 min (not shown).
CBP and glucose utilisation in extrastriatal brain areas
In the investigations of eBP and of glucose uti lisation, the Evans blue dye, used to delineate the spread of the injection, was invariably restricted to the body of the caudate nucleus and was in no case observed within either the adjacent globus pallidus or the nucleus accumbens. Pollowing intrastriatal injections of NPY (200 pmol), a significant reduc tion (p < 0. 02) in blood flow was also observed in the ipsilateral amygdala, which is located within the ventral forebrain. There was a tendency for eBP to be lower in animals receiving intrastriatal NPY in the ipsilateral entorhinal cortex (t = 2. 4) and ipsi lateral globus pallidus (t = 2. 3) and a tendency to wards higher levels of eBP in the contralateral sen sory motor cortex (t = 2. 76). The flow decreases following intrastriatal administration of NPY (200 pmol) resulted in areas of asymmetrical eBP that were bounded by the rhinal fissure and extended from the plane of the striatal injection site caudally to the plane of the substantia nigra (see Pig. 4). Similar though smaller reductions in blood flow in limbic areas were observed after intrastriatal injec tions of 2 and 20 pmol of NPY. After the intrastri atal administration of NPY, glucose utilisation was not modified significantly within the limbic areas of ventral forebrain in which the reductions in tissue blood flow were observed ( Table 3 ). In the over whelming majority of brain areas that were exam ined both ipsilateral and contralateral to the intra cerebral injection, NPY failed to alter either eBP or glucose utilisation.
Relationship between local CBP and local glucose utilisation
There was an excellent correlation (p < 0. 00(1) between local levels of blood flow and glucose uti lisation in the untreated hemisphere of the control animals (unilateral injection of vehicle); the overall ratio of blood flow to glucose use throughout the eNS was 1. 8 ml/fJ.mol-l (Pig. 5). This relationship Values are means ± SD; expressed as ml 100 g-I min-I. a Average CBF in the anterior (head) or posterior (tail) portion of the caudate nucleus. CBF for the darkest (max.) and lightest (min.) area within the body (mid) of the caudate nucleus over a 0.08-mm2 area.
b p < 0.02 for comparison between NPY and vehicle.
between tissue perfusion and oxidative metabolism contralateral to the intracerebral injection is indis tinguishable from that observed in parallel investi gations without any intracerebral intervention or drug administration (Tuor et aI. , 1986) . There is a similarly excellent correlation (p < 0. 001 ) between blood flow and glucose use both ipsilateral to intra striatal injection of vehicle (overall blood flow/ glucose use ratio 1. 9 mllfLmol-1 ) and contralateral to the intra striatal injection of NPY (overall blood flow/glucose use ratio 2.0 mllfLmol-1 ). However, in the hemisphere ipsilateral to NPY administration, although the relationship between blood flow and glucose used remained correlated, there was in- Values are means ± SD, expressed as fLmol 100 g-I min -I. a Average CBF in the anterior (head) or posterior (tail) portion of the caudate nucleus. CBF for the darkest (max.) and lightest (min.) area within the body (mid) of the caudate nucleus over a 0.08-mm 2 area. creased variability in the association and a lower overall ratio of blood flow to glucose use (1. 7 mllfLmol-1 ; Table 4 ). This reflects the significant departure of blood flow and glucose utilisation in the striatum and entorhinal cortex from their nor mal relationship after intrastriatal injection of NPY (200 pmol); p < 0.05 after application of the rela tively conservative approach of Greenhouse and Geisser (see McCulloch et aI. , 1982) (Fig. 5) .
DISCUSSION
Three separate aspects of the cerebrovascular physiology of NPY were examined in the present Although there were only minimal alterations in glucose use, pronounced reductions in blood flow were observed in the caudate nucleus ipsilateral to the injection of NPY.
study. An important feature of the investigation was that all aspects were examined in a single animal species, the rat, thereby avoiding variations in anat omy and responsiveness associated with interspe cies differences Hamel et aI., 1985) . cially (c) NPY injected into the striatum of con scious rats produces a decrease in striatal blood flow that is independent of a change in cerebral glu cose utilisation (i.e., the reduction in caudate blood flow following NPY administration is not related to metabolic changes within the caudate nucleus).
NPY perivascular nerve fibres
The presence of NPY in perivascular nerve fibres has been established using radioimmunoassay and immunocytochemical techniques in many species including humans, cat, guinea pig, and rat (Edvins son et aI., 1983 (Edvins son et aI., , 1984 (Edvins son et aI., , 1987a Allen et aI., 1984; Uddman et aI., 1985) . There is some variation be tween species in the density of NPY immunoreac tive nerve fibres found on cerebral arteries, and in addition, there is evidence that the concentration of NPY in the major cerebral arteries of the gerbil (Alafaci et aI., 1985) and human (Allen et aI., 1984; Edvinsson et aI., 1987b) is nonuniform, being greater in the rostral portions of the circle of Willis. The present study has confirmed the presence of well-developed plexuses of NPY immunoreactive nerve fibres on the rat cerebral arteries. In addition, NPY-like immunofluorescence was demonstrated to occur within several nerve fibres on rat lenticu lostriate arteries-vessels that enter the brain pa renchyma to supply blood to the caudate nucleus. This was seen at both the extra-and the intraparen chymal levels.
Vasomotor responses of cerebral arteries in vitro
The vasoconstrictor activity of NPY has been demonstrated previously in isolated cerebral arter ies of various species (Edvinsson et aI., 1983 (Edvinsson et aI., , 1984 (Edvinsson et aI., , 1987a . NPY applied to isolated rat middle cere bral arteries resulted in a concentration-dependent contraction with a 50% effective dose (ED50) value of 10 nM. The potency was similar to that observed in cerebral vessels from the cat and human. How ever, the maximal contraction of the pial arteries was slightly greater in cat and human than in rat (Edvinsson et aI., 1987a) . In a recent study Dacey et ai. (1988) revealed that NPY constricts rat intra parenchymal arterioles with the same potency as it constricts the middle cerebral artery in the present study. Thus, there does not appear to be major vari ation in responsiveness to NPY, either between species or between the different cerebral arteries being examined (Edvinsson et aI., 1984; Dacey et aI., 1988) .
Striatal blood flow and glucose use
The effects of the intrastriatal administration of NPY on local CBF and local glucose use were also examined. The highest amount of NPY (200 pmol) injected was estimated to produce a concentration of NPY within the caudate nucleus in the micromo lar range, assuming, simplistically, the distribution of the injectate over a sphere 2 mm in diameter and no degradation of the peptide (Myers, 1966) . This concentration of NPY produced maximal constric tion in vitro of rat middle cerebral arteries (present study) and intracerebral arterioles in vitro (Dacey et aI., 1988) . Furthermore, the threshold concentra tion of NPY in vitro (-2 nM) equates broadly with the concentration produced in vivo with the lowest dose studies (2 pmol) calculated using similar as sumptions. A recent study in the anaesthetised rat used the hydrogen clearance technique to examine blood flow in the striatum (Suzuki et aI., 1989) . The intracarotid injections of NPY (1,000-5,000 pmol) effected 20-40% reductions in striatal blood flow. The cerebrovascular effect developed slowly, reaching a maximum at -30 min post injection and lasting for 30-90 min depending on the dose in jected. In microapplication studies in cats, NPY produces an immediate constriction of cortical pial arterioles after it gains access to the subarachnoid space around the vessel (Edvinsson et aI., 1984) . The delayed onset noted by Suzuki et ai. (1989) , and the high amount of NPY that they administered (500 times greater than in the present study for threshold effect) may be a reflection of the difficulty a large peptide such as NPY faces in gaining access to the smooth muscle of cerebral resistance vessels from the vessel lumen (see MacKenzie et aI., 1976; Mc Culloch and Edvinsson, 1980) . Despite the apparent similarity between the results of the present study and those of Suzuki et ai. (1989) , the possibility that the effects of NPY are initiated at different anatom ical sites and via different mechanisms must be con sidered.
Investigation of feline cerebral arteries in vitro has provided insight into NPY's mode of action at the level of the vascular smooth muscle. The cere brovascular contraction evoked by NPY is absent in the presence of calcium antagonists and, as for other cerebral vasoconstricting agents, appears to be related to a flux of extracellular calcium into the vascular smooth muscle (Edvinsson et aI., 1983 (Edvinsson et aI., , 1987a . The constriction induced by NPY is not in fluenced either by a-adrenoreceptor blockade or by blockade of 5-hydroxytryptamine receptors. Simi larly, the response to NPY is unaffected by adding cocaine or propranolol to the bathing medium. Thus, specific NPY receptors may be present on the cerebrovascular smooth muscle, mediating its vasoconstrictor effects. Whether NPY itself in jected into the striatum may have caused a direct vasoconstriction or enhanced the effects of other intraparenchymal constrictor agents normally pre sent or released within the caudate nucleus cannot be deduced from the present data.
Purthermore, it is unclear whether the present data are indicative of a physiological role for NPY or whether they are of pharmacological signifi cance. This cannot be resolved with administration of exogenous NPY, but only by manipUlating en dogenous NPY with NPY antibodies, the only phar macological tool presently available for this peptide system.
CBP and glucose use in extrastriatal brain regions A major advantage of the auto radiographic tech niques used presently is their excellent spatial res olution, which provides measurements of local CBP and glucose use throughout the entire brain. Simple visual inspection of the auto radiograms revealed that there were striking reductions in local CBP in regions far removed from the striatal injection site. The decreases in blood flow in the limbic ventral fo rebrain (e.g., amygdala) occurred independently of any corresponding alterations in glucose use. These regions are unlikely to have been influenced directly by the constrictor effects of NPY. Their large distance from the injection site (>2 mm) makes simple diffusion of NPY through the tissue unlikely (Myers, 1966; Wolfson and Brown, 1983) . It is possible, however, that constriction originating in the striatum may be propagated back along arte rioles-arteries (Segal and Duling, 1986) , thereby in fluencing local CBP in regions unrelated to the cau date by either proximity or neuronal connections. An intriguing possibility is that either disturbances of striatal perfusion per se or alterations in the ac tivity of neuronal pathways originating within the caudate nucleus influenced blood flow elsewhere in the brain via polysynaptic circuits. While there is a remarkably close correspondence between the re gional patterns of the flow reductions observed in these remote regions and the distribution of dopa minergic innervation of these areas (Lindvall and Bjorklund, 1984; Pig. 4) , the implication of dopami nergic systems must be viewed as highly specula tive at the present time.
Relationship between local CBP and glucose use
The rate of local CBP is normally linked to that of local metabolic requirements by mechanisms that have yet to be clearly identified. In general, the administration of putative neurotransmitters-pep tides has produced alterations in CBP associated with changes in cerebral metabolic demand and not with primary effects on the cerebral circulation (MacKenzie et aI., 1976; Berntman et aI., 1978; Mc Culloch and Edvinsson, 1980; McCulloch et aI., 1982; Tuor et aI., 1986) . In the present study, a highly significant correlation between local CBP and local glucose use occurred under all conditions examined (either immunoreactive or contralateral to vehicle or NPY injection). However, there was an increased variability in the association between CBP and glucose use related to the discrete reduc tions in CBP occurring in regions that had no sig nificant changes in glucose utilisation. The demon stration of a dissociation between local CBP and glucose use is uncommon. Recently stimulation of the fastigial nucleus of the cerebellum resulted in primary cerebral vasodilation and increases in local blood flow. The blood flow changes occurred inde pendently of corresponding changes in cerebral me tabolism and in regions far removed from the site of stimulation (e.g., the cerebral cortex; Nakai et aI., 1983; Seylaz et aI., 1985) . This dissociation between local CBP and local glucose use, which has been initiated with either electrical stimuli or presently with pharmacological intracerebral manipulation, may be evidence of the functional role played by the cerebrovascular nerve fibres originating from the CNS itself.
Although the relationship between local CBP and local glucose utilisation is a central feature in cere brovascular pharmacology and pathophysiology, its experimental investigation presents a number of problems. The anatomically discrete nature of many of the local circulatory and metabolic distur bances in the CNS emphasises the need to employ measurement techniques with a high degree of spa tial resolution. Techniques employing quantitative autoradiography to assess local tracer concentra tions provide excellent spatial resolution, but most commonly, as in the present study, the measure ments of glucose use and CBP are derived from two separate series of experiments. It could be argued that double-nucleotide autoradiography, which per mits glucose use and CBP to be measured at the same site in a single animal (Lear et aI., 1981; Mies et aI., 1981; Sako et aI., 1984) , facilitates investiga tion of the blood flow-glucose use relationship, par ticularly so when the alterations in CBP are not neuroanatomic ally organised. A major though gen erally neglected problem with data derived from au toradiographic studies is the lack of independence in local CBP (or glucose use) in mUltiple areas (40 regions in the present study) derived from the same small group of animals (see Pord et aI., 1990) . The use of a Bonferroni correction of 40 would circum vent the problem of lack of independence and mul tiple comparisons (Wallenstein et aI., 1980) , but few alterations (none in the present study) in CBP or glucose use would achieve this extremely conser vative level of significance in many autoradiograph ic investigations. Rigorous statistical approaches that nonetheless allow meaningful alterations to be extracted from autoradiographic or tomographic studies are under development (Ford et al., 1990) . With simple statistical designs, it would be prudent to consider the probability level not as absolute, but as providing a hierarchy of significance of the re sponse in different regions, with the accepted level of probability (p < 0. 02) being wholly arbitrary. It should be emphasised that the dimensionality and the lack of independence in data sets are major sta tistical problems not just in autoradiography but in most areas of cerebrovascular research and influ ence greatly the degree of certainty with which par ticular studies can be replicated.
In conclusion, of the perivascular neuropeptides discovered to date, NPY is widely distributed with in cerebrovascular nerve fibres and is a potent vas oconstrictor of cerebral vessels both in vitro and in vivo. The ability of NPY to modify tissue perfusion irrespective of changes in energy consumption should substantially increase interest in the role of this neuropeptide in cerebrovascular regulation and pathophysiology.
